MedTrace Logo

The Use of 5mg Finasteride Versus 200mg Spironolactone and Topical 5% Minoxidil in Treating Postmenopausal Female Androgenetic Alopecia

NCT02483195 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2016-09-02

No results posted yet for this study

Summary

The investigators propose to conduct a head-to-head, randomized clinical trial to compare the effectiveness of Minoxidil with Spironolactone and Finasteride in treating postmenopausal females with Androgenetic Alopecia (AGA).

Conditions

  • Female Androgenetic Alopecia

Interventions

DRUG

5% Minoxidil

This will be a mixed combination of 5% Minoxidil and 200mg Spironolactone to be used once daily.

DRUG

200mg Spironolactone

This will be a mixed combination of 5% Minoxidil and 200mg Spironolactone to be used once daily.

DRUG

5mg Finasteride

This will be a mixed combination of 5mg Finasteride with placebo topical preparation to be used once daily.

OTHER

Placebo

This will be a mixed combination of 5mg Finasteride with placebo topical preparation to be used once daily.

Sponsors & Collaborators

  • University of Florida

    lead OTHER

Principal Investigators

  • Christina L. Mitchell, M.D. · University of Florida

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2018-08-31
Completion
2018-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02483195 on ClinicalTrials.gov